MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)

MMC、VICC

• 批准号: 9211638
• 负责人: Samuel Evans Adunyah
• 金额: $ 140.15万
• 依托单位: MEHARRY MEDICAL COLLEGE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-26 至 2021-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9211638
• 关键词: Address; Advisory Committees; African American; Age; Award; Awareness; Basic Science; Bioinformatics; Biometry; Cancer Burden; Cancer Center; Clinical Research; Clinical Trials; Collaborations; Communities; Community Health; Community Health Education; Core Facility; Development; Diagnosis; Discipline; Education; Education and Outreach; Effectiveness; Environment; Faculty; Fostering; General Hospitals; Goals; Growth; Health Educators; Incidence; Institution; Joints; Malignant Neoplasms; Measurable; Medical Students; Minority; Minority-Serving Institution; Mission; Monitor; NCI Center for Cancer Research; NCI-Designated Cancer Center; Outcome; Pathology; Pathway interactions; Peer Review; Population; Publications; Research; Research Infrastructure; Research Personnel; Research Project Grants; Resources; Series; Tennessee; Translational Research; Triad Acrylic Resin; Underrepresented Minority; Universities; Work; anticancer research; base; cancer education; cancer health disparity; cancer therapy; cancer type; career; career development; community organizations; design; disparity reduction; education research; graduate student; health disparity; healthcare community; high school; improved; improved outcome; medical schools; mortality; multidisciplinary; oncology; outreach; outreach program; programs; research and development; underserved minority; Address; Advisory Committees; African American; Age; Award; Awareness; Basic Science; Bioinformatics; Biometry; Cancer Burden; Cancer Center; Clinical Research; Clinical Trials; Collaborations; Communities; Community Health; Community Health Education; Core Facility; Development; Diagnosis; Discipline; Education; Education and Outreach; Effectiveness; Environment; Faculty; Fostering; General Hospitals; Goals; Growth; Health Educators; Incidence; Institution; Joints; Malignant Neoplasms; Measurable; Medical Students; Minority; Minority-Serving Institution; Mission; Monitor; NCI Center for Cancer Research; NCI-Designated Cancer Center; Outcome; Pathology; Pathway interactions; Peer Review; Population; Publications; Research; Research Infrastructure; Research Personnel; Research Project Grants; Resources; Series; Tennessee; Translational Research; Triad Acrylic Resin; Underrepresented Minority; Universities; Work; anticancer research; base; cancer education; cancer health disparity; cancer therapy; cancer type; career; career development; community organizations; design; disparity reduction; education research; graduate student; health disparity; healthcare community; high school; improved; improved outcome; medical schools; mortality; multidisciplinary; oncology; outreach; outreach program; programs; research and development; underserved minority

SUMMARY Particular emphasis is devoted in the US to identify the determinants of, and eventually remedies, for the disproportionate share of the cancer burden borne by underrepresented minorities. Incidence rates for many forms of cancer are higher among blacks than whites. The disparity is compounded by lower rates of relative survival for almost all cancers, so that age-adjusted mortality rates are substantially higher among African Americans than whites for about two-thirds of all types of cancers. Our Cancer Partnership provides an exceptional environment to focus the efforts of diverse investigators working across many disciplines to address health disparities in NCI designated cancer centers and to develop research infrastructure, capacity and effectiveness of minority-serving institutions. Collectively, these efforts offer the best opportunity to overcome cancer disparities and optimize research resources and infrastructure. Our Partnership has matured and developed strong, successful collaborative interactions based on excellence, true reciprocity and mutual benefit to achieve this goal. Moreover, this Partnership is geographically placed in a region with the highest cancer incidence in the US, pointing to the enormous potential for improved outcomes through the proposed work. We are dedicated to enhancing the strengths and eliminating the weaknesses of our three institutions as we move toward our shared goal of eliminating cancer disparities. The overall objectives of this competing renewal application are to: (1) increase and stabilize the competitive cancer research capability of Meharry Medical College (MMC) and Tennessee State University (TSU); (2) create stable, long-term collaborative relationships between MMC, TSU and the Vanderbilt Ingram Cancer Center (VICC) in cancer research, research education, career development and cancer outreach; (3) expand access to clinical trials for minority populations served by Nashville General Hospital (NGH)/MMC, and (4) improve the effectiveness of VICC research, career development, education and outreach activities specifically designed to benefit minority populations served by VICC. All activities will be monitored by an Internal Advisory Committee and the Program Steering Committee with representation from the NCI. A sustained and comprehensive Cancer Partnership is of immense benefit to the three participating institutions as well as the mid-South region of the US. The common mission statement for our Cancer Partnership is to conduct rigorous basic, translational and clinical research directed towards the reduction of disparities in the incidence and treatment of cancer through a multidisciplinary collaborative approach to research, education and community engagement. As a triad we will amplify cancer research capabilities in the greater Nashville academic and healthcare community, improve and document outcomes in the diagnosis and treatment of cancer in minority and underserved communities, minimize or eliminate measurable disparities in the incidence of cancer among minority populations, and fortify collaborations among the three partner organizations.

概括 特别强调美国，以确定，并最终补救的决定因素 代表性不足的少数民族所承受的癌症负担不成比例。许多人的发病率 黑人的癌症形式高于白人。相对率较低的差异使差异更加复杂 几乎所有癌症的生存率，因此非洲年龄调整的死亡率大大更高 美国人比白人，大约三分之二的癌症。我们的癌症伙伴关系提供了 杰出的环境集中于多个学科工作的各种研究人员的努力 解决NCI指定癌症中心的健康差异，并开发研究基础设施，容量 少数派服务机构的有效性。这些努力共同提供了最好的机会 克服癌症差异并优化研究资源和基础设施。我们的伙伴关系已经成熟 并建立了基于卓越，真正的互惠和相互互动的强大，成功的协作互动 实现这一目标的好处。此外，这种伙伴关系在地理位置上放置在一个最高的地区 美国的癌症发病率指出，通过拟议的 工作。我们致力于增强优势，并消除三个机构的劣势 我们朝着消除癌症差异的共同目标迈进。这个竞争的总体目标 更新应用是：（1）增加和稳定Meharry的竞争性癌症研究能力 医学院（MMC）和田纳西州立大学（TSU）； （2）创建稳定的长期协作 MMC，TSU和Vanderbilt Ingram癌症中心（VICC）在癌症研究中的关系， 研究教育，职业发展和癌症外展； （3）扩大少数民族临床试验的访问权限 由纳什维尔综合医院（NGH）/MMC服务的人群，（4）提高VICC的有效性 专门设计的研究，职业发展，教育和外展活动 VICC服务的种群。所有活动将由内部咨询委员会和 计划指导委员会由NC​​I代表。持续而全面的癌症 伙伴关系对三个参与机构以及中南部地区带来了巨大的好处 我们。我们癌症伙伴关系的常见使命陈述是进行严格的基本，翻译和 临床研究致力于通过通过 研究，教育和社区参与的多学科协作方法。作为三合会我们 将扩大纳什维尔学术和医疗保健社区的癌症研究能力，改善 并记录少数群体和服务不足社区癌症诊断和治疗的结果， 最小化或消除少数族裔癌症发生率的可测量差异，并加强 三个合作伙伴组织之间的合作。